When a TTL was not available, the leadership role fell onto the ER physician in charge, a senior surgical resident, or the general surgeon on call. Two groups were created for the analysis: the TTL group and the non-TTL group. Basic

demographic analysis was completed on the two groups involving age, sex, ISS, total LOS, ICU LOS, RTS, mechanism of injury and mortality. Chi square analysis was used to compare the ATLS protocol compliance between the two groups, as well as the mortality rate and Momelotinib clinical trial Readmission rate. Independent sample T-Test was used to compare the times to diagnostic imaging and Mann–Whitney U test (2 sample) was used to compare the number of items completed in the primary and secondary survey. Statistical analysis was performed using SPSS software, version 19 (IBM Corporation, Armonk, New York). this website Results A total of 781 patients were identified from the

ATR that met the inclusion criteria. Two hundred seventy three of the patients were excluded by criteria. A total of 508 patients were analyzed. Demographics Of the 508 patients, mean age was 39.7 (SD 17.6), 375 (73.8%) were male, and the mean ISS was 24.5 (SD 10.7) (Table 1). The majority of the patients (n = 467, 91.9%) suffered blunt trauma, whereas penetrating trauma and Fedratinib chemical structure burns accounted for 5.7% (n = 29) and 2.4% (n = 12) of the patients respectively. Overall mortality was 4.9% (n = 25). Table 1 Patient demographics   All patients (n = 508) TTL (n = 274) Non-TTL (n = 234) p-value Male 375 (73.8%) 210 (76.6%) 165 (70.5%)

0.117 Mean age (years) 39.7 (SD 17.6) 39.2 (SD 17.3) 40.3 (SD 18.0) 0.457 Mean ISS 24.5 (SD 10.7) 25.4 (SD 11.0) 23.5 (SD 10.2) 0.045 Mean ICU LOS (days) 3.7 (SD 9.0) 4.5(SD 9.8) 2.9 (SD 7.8) 0.040 Mean total LOS (days) 14.5 (SD 23.0) 16.2 (SD 28.1) 12.4 (SD 14.6) 0.050 RTS 6.15 (SD 3.1) 5.81 (SD 3.30) 6.55 (SD 2.82) 0.007 Mechanism of Monoiodotyrosine injury           Blunt 467 (91.9%) 248 (90.5%) 219 (93.6%)   Penetrating 29 (5.7%) 21 (7.7%) 8 (3.4%)   Burns 12 (2.4%) 5 (1.8%) 7 (3.0%) Mortality 25 (4.9%) 15 (5.5%) 10 (4.3%) 0.682 Readmission* 19 (4.0%) 9 (3.5%) 10 (4.5%) 0.642 ICU Intensive Care Unit, ISS Injury Severity Score, LOS Length of Stay, RTS Revised Trauma Score, TTL Trauma team leader. *Unplanned readmission within 60 days of discharge. Approximately half of the cases (53.9%, n = 274) had a TTL present. The TTL and non-TTL groups were comparable in terms of sex, age, mechanism of injury and mortality (Table 1). The RTS was lower and ISS higher in the TTL group compared to the non-TTL group (5.81 vs. 6.55, p = 0.007 and 25.4 vs. 23.5, p = 0.045 respectively), indicating a more severely injured patient population in the TTL group.